This observational analysis used wrist-worn activity-tracker data from participants in the UK Biobank to examine associations between walking volume, walking intensity, and mortality. The initial cohort comprised 103,684 participants who had been enrolled in the UK Biobank at ages 40–69 (enrolment 2006–2010). Participants wore activity trackers for seven consecutive days between 2013 and 2015. Researchers followed participants prospectively for mortality outcomes until November 2022, yielding a mean follow-up of approximately eight years.
The investigators excluded participants with missing activity data, a history of cardiovascular disease or cancer at baseline, and those who died in accidents during follow-up. After exclusions, 64,743 participants were analyzed for all-cause mortality (1,697 deaths) and 70,075 for cardiovascular mortality (502 deaths).
Daily walking volume was quantified as the number of steps recorded by the wrist-worn device. Stepping intensity was assessed using peak 30‑min cadence, defined as the average steps per minute across the 30 highest stepping minutes in a day (these 30 minutes need not be consecutive) and then averaged over the monitoring period. Peak 30‑min cadence served as the indicator of stepping intensity used in the analysis.
The study observed a graded association between step count and mortality, with the lowest all-cause mortality risk in people who accumulated roughly 7,500–10,000 steps per day. However, intensity modified those associations. For adults who took fewer than 5,000 steps per day, achieving a higher walking pace—measured as a peak 30‑min cadence greater than about 80 steps per minute—was associated with mortality risk similar to that of people who took more steps at a slower pace (for example, around 10,000 steps per day at lower cadence).
In short, two different stepping patterns—higher volume at a lower intensity and lower volume with higher intensity—were linked to similar levels of mortality risk in the sample analyzed.
The authors emphasize behavioral flexibility: step-based targets need not be uniform for everyone. For many middle-aged and older adults who face barriers to walking long distances or walking rapidly, either increasing step volume or increasing stepping intensity appears to be a viable route to lower risk. The investigators caution that this work is observational; the reported relationships are associations and do not prove that deliberately increasing the peak 30‑min cadence will necessarily lower mortality.
The study team highlighted that the steepest associations were seen among the least active adults (those accumulating fewer than 5,000 steps per day), suggesting that changes in intensity among low-activity individuals may yield notable differences in observed risk.
Independent commentators and the study authors offered physiologic explanations consistent with the findings. Increasing overall movement or exercising at higher intensity can improve blood pressure control, support healthy weight management, enhance insulin sensitivity, and reduce broader cardiometabolic risk factors. These mechanisms plausibly link both greater step counts and higher stepping intensity to reductions in all-cause and cardiovascular mortality observed in population studies.
The authors and external experts also underscored limits tied to study design: because the analysis is observational and used a single week of device-measured activity as the exposure, causal inferences are limited. The investigators excluded participants with preexisting cardiovascular disease or cancer and adjusted analyses accordingly, but residual confounding and measurement constraints inherent to accelerometer-based monitoring remain.
The study supports the message that both step count and walking pace matter, and that the most effective combination is the one an individual can maintain over time. For many people, modest increases in activity—either by walking more steps daily or by increasing the pace of steps they already take—could be associated with lower mortality risk.
Experts quoted in the report advised that the largest health gains often come from moving from no activity to some activity. Short bursts of movement throughout the day, a brisk 20–30 minute walk, taking stairs, or other feasible changes incorporated near-daily are likely to be beneficial if sustained. The investigators recommended that anyone with cardiovascular risk factors consult a clinician before markedly increasing exercise intensity.
Limitations cited in the article include the observational design (associations rather than proof of causation), the single-week activity measurement window, and the exclusions applied to the analytic sample. Specific intervention effects, optimal cadence thresholds for different age or clinical subgroups, and direct evidence that changing cadence lowers mortality were not reported in the source article.
Overall, the study adds to evidence that both walking more and walking faster are linked with lower mortality risk and that individuals and clinicians can consider either or both approaches depending on capacity and preference.